Skip to main navigation Skip to search Skip to main content

Clinical aspects of the Chagas' heart disease

  • Gopikrishna Punukollu
  • , Ramesh M. Gowda
  • , Ijaz A. Khan
  • , Victor S. Navarro
  • , Balendu C. Vasavada

Research output: Contribution to journalReview articlepeer-review

90 Scopus citations

Abstract

Chagas' heart disease, caused by protozoan Trypanosoma cruzi, is a common cause of cardiomyopathy in the Americas. Transmission of T. cruzi occurs through Reduviids, the kissing bugs. Less common ways of transmission are blood transfusion, congenital transmission, organ transplantation, laboratory accident, breastfeeding, and oral contamination. Infestation results in cardiac dysautonomia, myocardial apoptosis, and myocardial fibrosis. In acute phase, death is mostly caused by myocarditis and in chronic phase, it is mostly by irreversible cardiomyopathy. A majority of the patients with Chagas' disease remain in the latent phase of disease for 10 to 30 years or even for life. Specific anti-Chagas' therapy with trypanocide drugs is useful in acute phase but the management of chronic Chagas' heart disease is mostly empirical. The mortality during the acute phase of cardiac Chagas is around 5%. Five-year mortality of chronic Chagas' disease with cardiac dysfunction is above 50%. The clinical aspects of the Chagas' heart disease are concisely reviewed.

Original languageEnglish
Pages (from-to)279-283
Number of pages5
JournalInternational Journal of Cardiology
Volume115
Issue number3
DOIs
StatePublished - 14 Feb 2007
Externally publishedYes

Keywords

  • Chagas' heart disease
  • Chagasic cardiomyopathy
  • Congestive heart failure
  • Neurogenic cardiomyopathy
  • Trypanosoma cruzi

Fingerprint

Dive into the research topics of 'Clinical aspects of the Chagas' heart disease'. Together they form a unique fingerprint.

Cite this